Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall neurontinNeurontin, the brand name of the generic drug gabapentin, is prescribed to treat seizures commonly caused by epilepsy. The drug is also used to ease nerve pain that results from shingles.
The drug comes with a warning about side effects, including: dizziness, poor coordination or drowsiness; blurred or double vision and irregular eye movements; nausea and vomiting; or tremor.
Missing from the warning label is a mention of suicidal tendencies, which have recently been linked to the drug. Because the drug has only been approved for use in treating seizures and heat flashes from nerve diseases, the use of Neurontin to treat any other ailment could cause such unprecedented side effects, increasing the importance of only using the drug to for its approved purposes.
In 2003, Parke-Davis, the makers of Neurontin, were accused of improperly marketing the drug to treat diseases other than epilepsy, including chronic pain, migraine and bipolar disorder. A class action lawsuit was brought against the company by people claiming suicidal side effects as well as prescription use of the medication for an ailment other than epilepsy or shingles.
If the FDA has not approved a drug for a certain use, the manufacturer is not authorized to market that drug for any use other than the approved use. In the case of Parke-Davis and the Neurontin class action, people who have been prescribed the drug for uses other than epilepsy, specifically for bipolar disorder, are encouraged to talk to a lawyer about compensation from the class action.
The FDA has requested 14 drugmakers to check their study data to see if use of epilepsy drugs results in suicidal behavior or thoughts, giving the drugmakers six months to respond.
Sales of anti-seizure drugs in the U.S. during 2004 were th...
Just weeks after Pfizer and its Warner-Lambert Co. unit were penalized $430 million in federal and state courts for selling Neurontin for purposes that have not yet been FDA approved, the company is again under fire for fraudulent marketing practices. ...
The world''s largest drug manufacturer, Pfizer, Inc., agreed to pay at least $400 million in order to settle civil charges regarding kickbacks to encourage doctors to prescribe the anti-epileptic drug Neurontin for other purposes.
The se...